How to accelerate and scale AI in pharma R&D
Clear recommendations to help C-suite executives and senior leaders in biopharma organisations understand the benefits that AI can bring to drug discovery and how to implement and scale AI use.
Ensure top-down support with senior leadership buy-in
Assess organizational risk profile and define clear goals
Balance building core AI capabilities with strategic partnerships
Build a data- and digital-savvy workforce
Advocate for organizational data readiness and industry data standards
Our five, broad recommendations are based on:
An industry survey of 500 senior executives at leading biopharma organizations across nine countries,
Our experience working on the ground in partnership with biopharma organizations.